Affordable Access

deepdyve-link
Publisher Website

Are CIN3 risk or CIN3+ risk measures reliable surrogates for invasive cervical cancer risk?

Authors
  • Austin, R. Marshall1
  • Onisko, Agnieszka1, 2
  • Zhao, Chengquan1
  • 1 Department of Pathology, Magee-Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
  • 2 Faculty of Computer Science, Bialystok University of Technology, Bialystok, Poland
Type
Published Article
Journal
Journal of the American Society of Cytopathology
Publisher
American Society of Cytopathology. Published by Elsevier Inc.
Publication Date
Jul 29, 2020
Volume
9
Issue
6
Pages
602–606
Identifiers
DOI: 10.1016/j.jasc.2020.07.133
PMID: 32839150
PMCID: PMC7387921
Source
PubMed Central
Keywords
License
Unknown

Abstract

• Discuss ASCCP guideline. • CIN3 reliable surrogates for cervical cancer? • The Pittsburgh Cervical Cancer Screening Model.

Report this publication

Statistics

Seen <100 times